Association of PIK3CA Mutation With Prognosis and PAM50 Subtype in Early HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients With Early HER2+ Breast Cancer: Association With Prognosis and Integration With PAM50 Subtype
Clin. Cancer Res 2020 Aug 25;[EPub Ahead of Print], V Guarneri, MV Dieci, G Bisagni, AA Brandes, A Frassoldati, L Cavanna, A Musolino, F Giotta, A Rimanti, O Garrone, E Bertone, K Cagossi, O Nanni, F Piacentini, E Orvieto, G Griguolo, M Curtarello, L Urso, L Paré, N Chic, R D'Amico, A Prat, P ConteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.